What is Revecore?
Revecore Technologies is dedicated to simplifying and enhancing the hospital recovery process, aiming to remove obstacles that prevent healthcare facilities from acquiring essential resources for growth and ensuring patients receive the critical care they require. This singular focus drives the company's mission and passion within the healthcare sector.
How much funding has Revecore raised?
Revecore has raised a total of $7.5M across 1 funding round:
Unspecified
$7.5M
Unspecified (2012): $7.5M with participation from West End Holdings and FCA Venture Partners
Key Investors in Revecore
West End Holdings
West End Holdings is a private equity partnership that specializes in acquiring special situation businesses, focusing on providing leadership and capital to companies in the technology, healthcare services, and business services sectors. They aim to drive positive change and deliver successful outcomes for stakeholders, particularly for businesses seeking recapitalization and exit strategies.
FCA Venture Partners
FCA Venture Partners, evolving from Clayton Associates, is an investment firm that supports start-up and early-stage companies. Initially operating with an incubator model, they now manage venture partner funds, investing capital in promising early-stage ventures, with a continued focus on supporting entrepreneurs.
What's next for Revecore?
The recent influx of major enterprise-level funding positions Revecore for significant expansion and operational enhancement. This strategic capital infusion is expected to accelerate the company's efforts to break down barriers in healthcare recovery processes, enabling hospitals to access necessary resources more effectively. The company's commitment to its core mission suggests a future focused on technological advancements and broader market penetration within the healthcare industry.
See full Revecore company page
